Russia, Hualan Biological Bacterin agree to produce Sputnik V Covid-19 vaccine in China
Sign up now: Get ST's newsletters delivered to your inbox
A vial of Russia's Sputnik V vaccine.
PHOTO: REUTERS
MOSCOW (Reuters) - The Russian Direct Investment Fund (RDIF) sovereign wealth fund said on Monday (April 19) that it had agreed with Chinese manufacturer Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V Covid-19 vaccine in China.
RDIF said the two sides were committed to a long-term partnership in vaccine production.
This story is developing.
